Cited by 811Parkinson's Disease Mechanisms and TreatmentsGeriatric Care and Nursing HomesDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study

Aarsland, Dag, Larsen, Jan Petter, Tandberg, Elise, Laake, Knut·2000·Journal of the American Geriatrics Society

DOI 10.1111/j.1532-5415.2000.tb06891.x

Open this paper in CoChat — free account

Abstract

OBJECTIVES : To examine the rate and predictors of nursing home placement in patients with Parkinson's disease. DESIGN : Four‐year prospective study. SETTING : A population‐based study in western Norway PARTICIPANTS : 178 community‐dwelling subjects with Parkinson's disease. MEASUREMENTS : Main outcome measure was the time from baseline to nursing home admission. Baseline evaluation of motor symptoms (Unified Parkinson's Disease Rating Scale, UPDRS), cognition (clinical dementia interview, Gottfries, Bråne & Steen dementia scale, and Mini‐Mental State Examination), depression (clinical interview and the Montgomery & Åsberg Depression Rating Scale), and psychotic symptoms (UPDRS Thought Disorder item) were performed. RESULTS : Forty‐seven patients (26.4%) were admitted to a nursing home during the 4‐year study period. Institutionalized patients were older, had more advanced Parkinson's disease with more severe motor symptoms and impairment of activities of daily living, were cognitively more impaired, were more often living alone, and had more hallucinations than those who continued to live at home. Duration of disease, levodopa dose, and gender distribution did not differ between the two groups. A Cox proportional hazards linear regression analysis showed that old age, functional impairment, dementia, and hallucinations were independent predictors of nursing home admission. CONCLUSIONS : Both motor and neuropsychiatric symptoms contributed to institutionalization, but the presence of hallucinations was the strongest predictor. This finding indicates it is possible that effective treatment of hallucinations may reduce the need for institutionalization in patients with Parkinson's disease. J Am Geriatr Soc 48:938–942, 2000 .

Integrity signals

Registry

Crossref · 10.1111/j.1532-5415.2000.tb06891.x

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
The Parkinson Study Group (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401003 · Cited by 618
Mental symptoms in Parkinson's disease are important contributors to caregiver distress
Aarsland, D., Larsen, J. P., Karlsen, K., Lim, N. G., & Tandberg, E. (1999) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199910)14:10 · Cited by 484
Self-citation
Risk factors for nursing home placement in advanced Parkinson's disease
Goetz, C. G., & Stebbins, G. T. (1993) · Neurology · doi:10.1212/wnl.43.11.2227 · Cited by 460
A prospective study of long-term care institutionalization among the aged.
Branch, L. G., & Jette, A. M. (1982) · American Journal of Public Health · doi:10.2105/ajph.72.12.1373 · Cited by 440
The Occurrence of Depression in Parkinson's Disease
Tandberg, E. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020087019 · Cited by 413
Self-citation
Predictors of Institutionalization Among Caregivers of Patients With Alzheimer's Disease
Colerick, E. J., & George, L. K. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb04239.x · Cited by 393
Prevalence and Clinical Correlates of Psychotic Symptoms in Parkinson Disease
Aarsland, D., Larsen, J. P., Cummings, J. L., & Laake, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.595 · Cited by 347
Self-citation

Show all 21 references

Research works printed but not linked: 2

Fahn S, 1987, Recent Development in Parkinson's Disease, 153
1987, Diagnostic and Statistical Manual of Mental Disorders

Sorted by citations

Items 301–400 of 807

Consensus guidelines for the definition of the end stage of disease and last days of life and criteria for medical judgment
Lee, S., Kim, S., Choi, Y. S., Heo, D. S., Baik, S., Choi, B. M., Kim, D., Moon, J. Y., Park, S. Y., Chang, Y. J., et al. (2018) · Journal of Korean Medical Association · doi:10.5124/jkma.2018.61.8.509 · Cited by 31
Characteristics of Patients with Late-Stage Parkinsonism Who are Nursing Home Residents Compared with those Living at Home
Hosking, A., Hommel, A. L. A. J., Lorenzl, S., Coelho, M. M., Ferreira, J. J., Meissner, W. G., Odin, P., Bloem, B. R., Dodel, R. C., & Schrag, A. E. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.06.025 · Cited by 31
Identification of EEG Dynamics During Freezing of Gait and Voluntary Stopping in Patients With Parkinson’s Disease
Cao, Z., John, A. R., Chen, H., Martens, K. A. E., Georgiades, M., Gilat, M., Nguyen, H. T., Lewis, S. J. G., & Lin, C. (2021) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2021.3107106 · Cited by 33
Antipsychotics for the management of psychosis in Parkinson's disease: systematic review and meta-analysis
Jethwa, K. D., & Onalaja, O. A. (2015) · BJPsych Open · doi:10.1192/bjpo.bp.115.000927 · Cited by 32
Scales to evaluate psychosis in Parkinson's disease
Goetz, C. G. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70777-1 · Cited by 30
The patient with Parkinson’s disease: Part I–Treating the motor symptoms; Part II–Treating the nonmotor symptoms
Hoffman‐Snyder, C., & Adler, C. H. (2007) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2007.00211.x · Cited by 30
Neuropsychiatric co-morbidities in non-demented Parkinson′s disease
Goyal, V., Rai, N. K., Kumar, N. K., Shukla, G., Srivastava, A., Singh, S., & Behari, M. (2014) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.144287 · Cited by 30
Parkinson disease: managing a complex, progressive disease at all stages.
Giroux, M. (2007) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.74.5.313 · Cited by 29
The Case for Antipsychotics in Dementia with Lewy Bodies
Armstrong, M. J., & Weintraub, D. A. (2016) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12383 · Cited by 29
Neuropsychologic assessment in collaborative Parkinson's disease research: A proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington
Watson, G. S., Cholerton, B., Gross, R. G., Weintraub, D. A., Zabetian, C. P., Trojanowski, J. Q., Montine, T. J., Siderowf, A. D., & Leverenz, J. B. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.07.006 · Cited by 29
Increased levels of 5‐HT1A receptor binding in ventral visual pathways in Parkinson's disease
Huot, P., Johnston, T. H., Visanji, N. P., Darr, T., Pires, D., Hazrati, L., Brotchie, J. M., & Fox, S. H. (2012) · Movement Disorders · doi:10.1002/mds.24964 · Cited by 29
Smoking and cognitive function in Parkinson's disease
Weisskopf, M. G., Grodstein, F., & Ascherio, A. (2007) · Movement Disorders · doi:10.1002/mds.21373 · Cited by 30
SLEEP DISORDERS IN PARKINSON'S DISEASE
Abdelgabar, A., & Sharma, J. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10615.x · Cited by 29
Can your house keep you out of a nursing home?
Diepstraten, M., Douven, R., & Wouterse, B. (2020) · Health Economics · doi:10.1002/hec.4001 · Cited by 28
Progress in Clinical Neurosciences: Parkinson's Disease with Dementia and Dementia with Lewy Bodies
Camicioli, R. M., & Fisher, N. (2004) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100002791 · Cited by 28
Cognitive Impairment and Mortality in a Population-Based Parkinson’s Disease Cohort
Keener, A. M., Paul, K. C., Folle, A. D., Bronstein, J. M., & Ritz, B. R. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-171257 · Cited by 28
Nonmotor complications of Parkinson disease
Fernandez, H. H., Gálvez-Jiménez, N., & Fernandez, H. H. (2012) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.79.s2a.03 · Cited by 27
Course, Prognosis, and Management of Psychosis in Parkinson's Disease:Are Current Treatments Really Effective?
Zahodne, L. B., & Fernandez, H. H. (2008) · CNS Spectrums · doi:10.1017/s1092852900017296 · Cited by 27
IN-HOME-PD: The effects of longitudinal telehealth-enhanced interdisciplinary home visits on care and quality of life for homebound individuals with Parkinson's disease
Fleisher, J. E., Hess, S., Klostermann, E. C., Lee, J., Myrick, E., Mitchem, D., Niemet, C. J., Woo, K., Sennott, B. J., Sanghvi, M., et al. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.07.017 · Cited by 27
Evaluation and management of the non-motor features of Parkinson’s disease
Wishart, S., & Macphee, G. J. A. (2010) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310387847 · Cited by 27
Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: Relationship to motor disability and cognitive deficits: A pilot study
Rasovska, H., & Rektorová, I. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.07.048 · Cited by 27
Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial
Achey, M. A., Beck, C. A., Beran, D. B., Boyd, C. M., Schmidt, P. N., Willis, A. W., Riggare, S. S., Simone, R. B., Biglan, K. M., & Dorsey, E. R. (2014) · Trials · doi:10.1186/1745-6215-15-465 · Cited by 27
Hallucinations and conscious access to visual inputs in Parkinson’s disease
Lefebvre, S., Baille, G., Jardri, R., Plomhause, L., Szaffarczyk, S., Defebvre, L., Thomas, P., Delmaire, C., Pins, D., & Dujardin, K. (2016) · Scientific Reports · doi:10.1038/srep36284 · Cited by 27
Regional volumetric change in Parkinson's disease with cognitive decline
Gee, M., Dukart, J., Draganski, B., Martin, W. R. W., Emery, D. J., & Camicioli, R. M. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.12.030 · Cited by 27
Cognitive Training in Parkinson’s Disease: A Review of Studies from 2000 to 2014
Glizer, D., & MacDonald, P. A. (2016) · Parkinson s Disease · doi:10.1155/2016/9291713 · Cited by 30
Heart Rate Changes Prior to Freezing of Gait Episodes Are Related to Anxiety
Economou, K., Quek, D. Y. L., MacDougall, H. G., Lewis, S. J. G., & Martens, K. A. E. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202146 · Cited by 26
Cortical atrophy is associated with cognitive impairment in Parkinson’s disease: a combined analysis of cortical thickness and functional connectivity
Zhu, Y., Yang, B., Zhou, C., Gao, C., Hu, Y., Yin, W. F., Yin, K., Zhu, Y., Jiang, G., Ren, H. J., et al. (2022) · Brain Imaging and Behavior · doi:10.1007/s11682-022-00714-w · Cited by 27
Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT 1A Agonist, in Patients With Parkinson Disease Psychosis
Isaacson, S., Goldstein, M., Pahwa, R., Singer, C., Klos, K. J., Pucci, M., Zhang, Y., CRANDALL, D. T., Koblan, K. S., NAVIA, B. A., et al. (2023) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200175 · Cited by 26
Polymorphisms in the dopamine transporter gene are associated with visual hallucinations and levodopa equivalent dose in Brazilians with Parkinson's disease
Schuh, A. F. S., Francisconi, C. L. M., Altmann, V., Monte, T. L., Callegari-Jacques, S. M., Rieder, C. R. D. M., & Hutz, M. H. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001666 · Cited by 27
Physical Activity across Frailty Phenotypes in Females with Parkinson’s Disease
Roland, K. P., Cornett, K., Theou, O., Jakobi, J. M., & Jones, G. R. (2012) · Journal of Aging Research · doi:10.1155/2012/468156 · Cited by 26
Pimavanserin, a novel antipsychotic for management of Parkinson’s disease psychosis
Kianirad, Y., & Simuni, T. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1369405 · Cited by 26
Pharmacologic Treatment Expectations in the Management of Dementia with Lewy Bodies
Kaufer, D. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000074680 · Cited by 26
Theta oscillations and minor hallucinations in Parkinson’s disease reveal decrease in frontal lobe functions and later cognitive decline
Bernasconi, F., Pagonabarraga, J., Bejr‐Kasem, H., Martínez‐Horta, S., Marín‐Lahoz, J., Horta‐Barba, A., Kulisevsky, J., & Blanke, O. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00080-6 · Cited by 25
Optimizing care of residents with Parkinsonism in supervised facilities
Makoutonina, M., Iansek, R., & Simpson, P. M. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.010 · Cited by 25
Nonmotor Symptoms in a Malaysian Parkinson’s Disease Population
Azmin, S., Anuar, A. M. K., Tan, H. J., Nafisah, W. Y., Raymond, A. A., Hanita, O., Shah, S. A., & Norlinah, M. I. (2014) · Parkinson s Disease · doi:10.1155/2014/472157 · Cited by 26
Functional levels and nurse workload of elderly awaiting nursing home placement and nursing home residents: a comparative study
Fjelltun, A. S., Henriksen, N. O., Norberg, A., Gilje, F., & Normann, H. K. (2009) · Scandinavian Journal of Caring Sciences · doi:10.1111/j.1471-6712.2008.00672.x · Cited by 25
Associations between family history of Parkinson's disease and dementia and risk of dementia in Parkinson's disease: A community‐based, longitudinal study
Kurz, M. W., Larsen, J. P., Kvaløy, J. T., & Aarsland, D. (2006) · Movement Disorders · doi:10.1002/mds.21144 · Cited by 25
Self-citation
Movement disorders emergencies. Part 1: Hypokinetic disorders.
Robottom, B., Weiner, W. J., & Factor, S. A. (2011) · PubMed · doi:10.1001/archneurol.2011.84 · Cited by 25
Systematic Literature Review of Quetiapine for the Treatment of Psychosis in Patients With Parkinsonism
Chen, J. J., Hua, H., Massihi, L., Portillo, I., Alipour, A., Ondo, W. G., & Dashtipour, K. (2019) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.18080180 · Cited by 25
Treatment of behavioural symptoms and dementia in Parkinson's disease
Hanagasi, H. A., & Emre, M. (2005) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2005.00317.x · Cited by 24
Drug treatments for the neuropsychiatric complications of Parkinson’s disease
Connolly, B. S., & Fox, S. H. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.142 · Cited by 24
Neuroanatomical and prognostic associations of depression in Parkinson’s disease
Badenoch, J., Paris, A., Jacobs, B. M., Noyce, A. J., Marshall, C. R., & Waters, S. (2024) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-333007 · Cited by 24
Sentence processing in Lewy body spectrum disorder: The role of working memory
Gross, R. G., McMillan, C. T., Chandrasekaran, K., Dreyfuss, M., Ash, S., Avants, B., Cook, P. A., Moore, P., Libon, D. J., Siderowf, A. D., et al. (2012) · Brain and Cognition · doi:10.1016/j.bandc.2011.12.004 · Cited by 24
Mild Cognitive Impairment in Parkinson’s Disease: Impact on Caregiver Outcomes
Szeto, J. Y. Y., Mowszowski, L., Gilat, M., Walton, C. C., Naismith, S. L., & Lewis, S. J. G. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160823 · Cited by 24
Palliative Care for Patients and Families With Parkinson's Disease
Bouça‐Machado, R., Titova, N., Chaudhuri, К. R., Bloem, B. R., & Ferreira, J. J. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.02.017 · Cited by 24
Familial Occurrence of Dementia and Parkinsonism
Kurz, M. W., Schlitter, A. M., Larsen, J. P., Ballard, C. G., & Aarsland, D. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000095159 · Cited by 24
Self-citation
Palliative care for patients with Parkinson’s disease: study protocol for a mixed methods study
Lennaerts, H. H., Groot, M. M., Steppe, M., van der Steen, J. T., den Brand, M. V., van Amelsvoort, D., Vissers, K. C. P., Munneke, M., & Bloem, B. R. (2017) · BMC Palliative Care · doi:10.1186/s12904-017-0248-2 · Cited by 23
Differential Temporal Perception Abilities in Parkinson’s Disease Patients Based on Timing Magnitude
Bernardinis, M., Atashzar, S. F., Jog, M., & Patel, R. V. (2019) · Scientific Reports · doi:10.1038/s41598-019-55827-y · Cited by 23
Risk factors for minor hallucinations in Parkinson's disease
Omoto, S., Murakami, H., Shiraishi, T., Bono, K., Umehara, T., & Iguchi, Y. (2020) · Acta Neurologica Scandinavica · doi:10.1111/ane.13380 · Cited by 23
Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients
Isaacson, S., Ballard, C. G., Kreitzman, D. L., Coate, B., Norton, J. C., Fernandez, H. H., Ilic, T. V., Azulay, J., Ferreira, J. J., Abler, V., et al. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.04.012 · Cited by 23
Pimavanserin and Parkinson’s Disease Psychosis: A Narrative Review
Rissardo, J. P., Durante, Í., Sharon, I., & Caprara, A. L. F. (2022) · Brain Sciences · doi:10.3390/brainsci12101286 · Cited by 23
Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson’s Disease Psychosis: Systematic Review and Network Meta-Analysis
Yunusa, I. U., Rashid, N., Seyedin, R., Paratane, D., & Rajagopalan, K. (2023) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887231154933 · Cited by 25
PD-related psychosis: pathophysiology with therapeutical strategies
Wolters, E. C. (2006) · Springer eBooks · doi:10.1007/978-3-211-33328-0_4 · Cited by 23
Care requirements of a prevalent population of people with idiopathic Parkinson's disease
Porter, B., Henry, S. R., Gray, W. K., & Walker, R. W. (2009) · Age and Ageing · doi:10.1093/ageing/afp199 · Cited by 23
Models of probabilistic category learning in Parkinson’s disease: Strategy use and the effects of L-dopa
Speekenbrink, M., Lagnado, D. A., Wilkinson, L., Jahanshahi, M., & Shanks, D. R. (2009) · Journal of Mathematical Psychology · doi:10.1016/j.jmp.2009.07.004 · Cited by 23
New Thoughts on Thought Disorders in Parkinson's Disease: Review of Current Research Strategies and Challenges
Goldman, J. G. (2011) · Parkinson s Disease · doi:10.4061/2011/675630 · Cited by 22
Gamified Dual-Task Training for Individuals with Parkinson Disease: An Exploratory Study on Feasibility, Safety, and Efficacy
Chua, L.-K., Chung, Y., Bellard, D., Swan, L., Gobreial, N., Romano, A., Glatt, R. M., Bonaguidi, M. A., Lee, D. J., Jin, Y., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312384 · Cited by 22
Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease
Guttuso, T. J., Sirica, D., Tosun, D., Zivadinov, R., Pasternak, O., Weintraub, D. A., Baglio, F., & Bergsland, N. (2021) · Movement Disorders · doi:10.1002/mds.28886 · Cited by 22
IN-HOME-PD Caregivers: The effects of a combined home visit and peer mentoring intervention for caregivers of homebound individuals with advanced Parkinson's disease
Fleisher, J. E., Suresh, M., Klostermann, E. C., Lee, J., Hess, S., Myrick, E., Mitchem, D., Woo, K., Sennott, B. J., Witek, N. P., et al. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.11.014 · Cited by 26
Clinical EEG in cognitively impaired patients with Parkinson's Disease
Schlede, N., Zimmermann, R., Ehrensperger, M. M., Gschwandtner, U., Hardmeier, M., Hatz, F., Monsch, A. U., Naegelin, Y., & Fuhr, P. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.05.034 · Cited by 22
The Neuro-Ophthalmological Assessment in Parkinson’s Disease
Borm, C. D. J. M., Śmiłowska, K., de Vries, N. M., Bloem, B. R., & Theelen, T. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-181523 · Cited by 22
Neurobehavioral aspects of movement disorders
Glosser, G. (2001) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70033-5 · Cited by 23
Defining meaningful outcome measures in trials of disease-modifying therapies in Parkinson's disease
Evans, J., & Barker, R. A. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.548807 · Cited by 21
A comprehensive overview of the neuropsychiatry of Parkinson's disease: A review
Khan, M. A., Quadri, S. A., & Tohid, H. (2017) · Bulletin of the Menninger Clinic · doi:10.1521/bumc.2017.81.1.53 · Cited by 21
Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of Dopamine
Dave, S., Weintraub, D., Aarsland, D., & Ffytche, D. H. (2019) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12851 · Cited by 21
Self-citation
Experience of care home residents with Parkinson's disease: Reason for admission and service use
Walker, R. W., Palmer, J., Stancliffe, J., Wood, B. H., Hand, A., & Gray, W. K. (2013) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12204 · Cited by 21
Patient-reported Needs, Non-motor Symptoms, and Quality of Life in Essential Tremor and Parkinson’s Disease
Lageman, S. K., Cash, T. V., & Mickens, M. (2014) · Europe PMC (PubMed Central) · doi:10.7916/d8rf5s4j · Cited by 20
Association of Caregiver Depression Risk With Patient Outcomes in Parkinson Disease
Rashid, R., Aamodt, W. W., Horn, S. R. G.-V., & Dahodwala, N. A. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.27485 · Cited by 20
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
Fusaroli, M., Polizzi, S., Menestrina, L., Giunchi, V., Pellegrini, L., Raschi, E., Weintraub, D. A., Recanatini, M., Castellani, G., Ponti, F. D., et al. (2024) · Drug Safety · doi:10.1007/s40264-024-01471-z · Cited by 20
Satisfaction with life related to functionality in active elderly people.
Hernández, C. R., López, V., & Ortiz, T. (2009) · Actas Españolas de Psiquiatría · Cited by 21
Predictors of entry to the nursing home: Does length of follow-up matter?
Cohen‐Mansfield, J., & Wirtz, P. W. (2011) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2010.12.009 · Cited by 22
The 100 most-cited articles in Parkinson’s disease
Xue, J., Hu, Z., Lai, P., Cai, D.-Q., & Wen, E. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3450-y · Cited by 20
Correlation of Sleep Disturbance and Cognitive Impairment in Patients with Parkinson’s Disease
Kim, E., Baek, J. H., Shin, D. J., Park, H.-M., Lee, Y., Park, K.-H., Shin, D. H., Noh, Y., & Sung, Y. H. (2014) · Journal of Movement Disorders · doi:10.14802/jmd.14003 · Cited by 20
Can levodopa prevent cognitive decline in patients with Parkinson's disease?
Ikeda, M., Kataoka, H., & Ueno, S. (2017) · Europe PMC (PubMed Central) · Cited by 20
Perspective on Pimavanserin and the SAPS-PD: Novel Scale Development as a Means to FDA Approval
Schubmehl, S., & Sussman, J. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.06.001 · Cited by 19
Analysis of Transition of Patients with Parkinson’s Disease into Institutional Care: A Retrospective Pilot Study
Jensen, I., Lescher, E., Stiel, S., Wegner, F., Höglinger, G. U., & Klietz, M. (2021) · Brain Sciences · doi:10.3390/brainsci11111470 · Cited by 19
Hallucinations and delusions associated with Parkinson’s disease psychosis: safety of current treatments and future directions
Isaacson, S., & Citrome, L. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2069240 · Cited by 19
Driving and dementia: a clinician's guide
Wilson, S., & Pinner, G. (2013) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.111.009555 · Cited by 19
Virtual reality walking and dopamine: Opening new doorways to understanding freezing of gait in Parkinson's disease
Matar, E., Shine, J. M., Naismith, S. L., & Lewis, S. J. G. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.06.054 · Cited by 19
Prevalence and Characteristics of Dementia in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., & Kragh-Sørensen, P. (2015) · Cited by 19
Self-citation
Informant‐ and S elf‐ A ppraisals on the P sychosis and H allucinations Q uestionnaire ( P sycH‐ Q ) E nhances D etection of V isual H allucinations in P arkinson's D isease
Muller, A. J., Mills, J. M. Z., O’Callaghan, C., Naismith, S. L., Clouston, P. D., Lewis, S. J. G., & Shine, J. M. (2018) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12683 · Cited by 19
Cognitive and behavioural impairment in Parkinson's disease
Merims, D., & Freedman, M. (2008) · International Review of Psychiatry · doi:10.1080/09540260802095123 · Cited by 21
Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease
Wang, M., Lian, P.-W., Yeh, C., Yen, C.-H., Ma, K.-H., & Chan, A. L. F. (2011) · Movement Disorders · doi:10.1002/mds.23719 · Cited by 19
Identifying clinical features and blood biomarkers associated with mild cognitive impairment in Parkinson disease using machine learning
Deng, X., Ning, Y., Saffari, S. E., Xiao, B., Niu, C., Ng, S. Y., Chia, N. S. Y., Choi, X., Heng, D. L., Tan, Y. J., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.15785 · Cited by 18
Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline
Sampedro, F., Marín‐Lahoz, J., Martínez‐Horta, S., Pagonabarraga, J., & Kulisevsky, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00394 · Cited by 18
CLU rs11136000 Promotes Early Cognitive Decline in Parkinson's Disease
Sampedro, F., Marín‐Lahoz, J., Martínez‐Horta, S., Pérez‐González, R., Pagonabarraga, J., & Kulisevsky, J. (2020) · Movement Disorders · doi:10.1002/mds.27949 · Cited by 18
Psychomotor processing and functional decline in Parkinson's disease predicted by the Purdue Pegboard test
Hinkle, J. T., & Pontone, G. M. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5492 · Cited by 18
Chapter 12 Dementia In Parkinson's Disease
Robottom, B., & Weiner, W. J. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)00412-7 · Cited by 18
Fluctuating Cotard Syndrome in a Patient With Advanced Parkinson Disease
Solla, P., Cannas, A., Orofino, G., & Marrosu, F. (2015) · The Neurologist · doi:10.1097/nrl.0000000000000010 · Cited by 18
Racial and Ethnic Comparisons of Nursing Home Residents at Admission
Buchanan, R. J., Rosenthal, M. J., Graber, D. R., Wang, S., & Kim, M. (2008) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2008.04.012 · Cited by 18
Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease
Reese, J. P., Dams, J., Winter, Y., Balzer‐Geldsetzer, M., Oertel, W. H., & Dodel, R. C. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.677435 · Cited by 18
Management of visual hallucinations in dementia and Parkinson’s disease
Swann, P., & O'Brien, J. T. (2018) · International Psychogeriatrics · doi:10.1017/s1041610218001400 · Cited by 21
Aberrant resting-state oscillatory brain activity in Parkinson's disease patients with visual hallucinations: An MEG source-space study
Dauwan, M., Hoff, J. I., Vriens, E. M., Hillebrand, A., Stam, C. J., & Sommer, I. E. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101752 · Cited by 19
Validity of the medication administration test among older adults with and without dementia
Schmidt, K. S., & Lieto, J. M. (2005) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2005.12.003 · Cited by 18
High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias
Storch, A., Trenkwalder, C., Oehlwein, C., Winkelmann, J., Polzer, U., Hundemer, H., & Schwarz, J. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.03.005 · Cited by 18
Illusory Responses across the Lewy Body Disease Spectrum
Shahid, M., Rawls, A., Ramirez, V., Ryman, S. G., Santini, V. E., Yang, L., Sha, S. J., Hall, J. N., Montine, T. J., Lin, A., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26574 · Cited by 17
Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial
Weintraub, D. A., Espay, A. J., Sharma, V. D., Tariot, P. N., Abler, V., Pathak, S. S., & Stankovic, S. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105951 · Cited by 17
Neuroimaging and plasma evidence of early white matter loss in Parkinson’s disease with poor outcomes
Zarkali, A., Hannaway, N., McColgan, P., Heslegrave, A., Veleva, E., Laban, R., Zetterberg, H., Lees, A. J., Fox, N. C., & Weil, R. S. (2024) · Brain Communications · doi:10.1093/braincomms/fcae130 · Cited by 18
Associations Between Neuropsychiatric Symptoms and Inflammation in Neurodegenerative Dementia: A Systematic Review
Swann, P., Mirza-Davies, A., & O'Brien, J. T. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s385825 · Cited by 19
“DASH” symptoms in patients with Parkinson’s disease: Red flags for early cognitive decline
Naismith, S. L., & Lewis, S. J. G. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2010.07.106 · Cited by 17

Authors: Aarsland, D., Larsen, J. P., Tandberg, E., & Laake, K.
Affiliations: Stavanger University Hospital (NO)
Oslo University Hospital (NO)
Corresponding author: Aarsland, Dag
ORCID: Aarsland, Dag
Venue: Journal of the American Geriatrics Society
Publisher: Wiley
Published: 2000-08
Volume: 48
Issue: 8
Pages: 938-942
ISSN: 0002-8614 (ISSN-L)
1532-5415
DOI: 10.1111/j.1532-5415.2000.tb06891.x
OpenAlex: W2083220625
Cited by: 811
References: 21
Citations by year: 2026: 15 · 2025: 30 · 2024: 30 · 2023: 33 · 2022: 33 · 2021: 42 · 2020: 64 · 2019: 36 · 2018: 35 · 2017: 36 · 2016: 37 · 2015: 32 · 2014: 42 · 2013: 42 · 2012: 33
FWCI: 7.66
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 5382 d)
Locations: Journal of the American Geriatrics Society (publishedVersion)
PubMed (publishedVersion)
Journal of the American Geriatrics Society
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Parkinson's disease, nursing home admission, institutionalization, predictors of institutionalization, hallucinations, dementia, functional disability, activities of daily living, motor symptoms, neuropsychiatric symptoms, depression, community-dwelling patients
MeSH terms: Activities of Daily Living, Adult, Aged, Aged, 80 and over, Dementia, Female, Hallucinations, Humans, Male, Middle Aged, Norway, Nursing Homes, Parkinson Disease, Patient Admission, Predictive Value of Tests, Prospective Studies, Psychiatric Status Rating Scales, Risk Factors, Severity of Illness Index, Geriatric Assessment, Linear Models, Proportional Hazards Models, Age Distribution, Community Health Planning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks